IBRANCE 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
IBRANCE 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Pending
Register Number
1161147012
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Apr 29, 2020
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1161147012
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✗
Commercialized
No
CIMA AEMPS Classification
INGREDIENTS (1)
PALBOCICLIBActive
Quantity: 100 mg
Name: PALBOCICLIB
ATC CLASSIFICATION (3)
L01E
L01EF
L01EF01